<?xml version="1.0" encoding="UTF-8"?>
<records xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="http://www.doaj.org/schemas/doajArticles.xsd">


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2021-08-05</publicationDate>
              <volume>6</volume>
              <issue>2</issue>
              <startPage>44</startPage>
              <endPage>50</endPage>
              <doi>10.26663/cts.2021.0009</doi>
              <publisherRecordId>136</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Is primary thoracic ewing sarcoma aggressive than others? seventeenyears’ experience</title>
                <authors>
                              <author>
                                <name>Seray  Hazer</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Göktürk  Fındık</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Koray  Aydoğdu</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Yetkin  Ağaçkıran</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Selim Şakir Erkmen Gülhan</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Mustafa Şevki Demiröz</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Pınar  Bıçakçıoğlu</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Sadi  Kaya</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, University of Health Sciences, Ankara Atatürk Chest Diseases and Thoracic Surgery Training and Research Hospital, Ankara, Turkey</affiliationName><affiliationName affiliationId="2">Department of Pathology, University of Health Sciences, Ankara Atatürk Chest Diseases and Thoracic Surgery Training and Research Hospital, Ankara, Turkey</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background:&lt;/b&gt; Ewing sarcoma (ES) is an uncommon aggressive malignant tumor of the bone and/or
soft tissue and belongs to peripheral primitive neuroectodermal tumor (PNET) family of tumors. Bone
PNETs primarily arise from the diaphysis of long bones, where as soft tissue PNETs are most commonly
found in the chest wall. Multidisciplinary treatments, including chemotherapy, surgery, radiotherapy, or
all three combined, improve the survival of patients with localized ES. However, the best approach to
achieve local control remains controversial.&lt;p&gt;
&lt;b&gt;Materials and Methods:&lt;/b&gt; We retrospectively analysed the medical records and pathology data of 14
patients (8 male, 6 female; mean age, 23.2 [range, 4-54] years) with primary thoracic ES who underwent
surgery in our clinic between January 2002 and December 2019. In addition, the treatment modalities
and tumor-related factors of chest wall ES and lung parenchyma were evaluated.&lt;p&gt;
&lt;b&gt;Results: &lt;/b&gt;The most frequent complaint was chest pain (n = 7). In 10 patients, the tumor originated
from the ribs, whereas the remaining 4 patients had lung parenchymal tumors. Ten patients underwent
complete tumor excision with chest wall resection, one patient underwent lower lobectomy with chest
wall resection, and three patients underwent complete tumor excision via wedge resection. All patients
were treated with chemotherapy, except two who underwent bone marrow transplantation. The median
follow-up was 31.6 (range, 2-84) months. Relapses were seen in 5 cases in the median 19.8th (range,
4-60) month.&lt;p&gt;
&lt;b&gt;Conclusions:&lt;/b&gt; Complete tumor resection is the most effective treatment for thoracic ES and multimodal
therapy (surgical resection, chemotherapy, and local radiation therapy), which is recommended
when indicated, constitutes the optimal treatment for ES. Although relapses occur within the early
postoperative period, late relapses are not uncommon. The follow-up periods must be short and should
be maintained long term for late relapses.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=136</fullTextUrl>
              <keywords><keyword>Ewing’s sarcoma</keyword><keyword>chest wall</keyword><keyword>chemotherapy</keyword><keyword>surgery</keyword><keyword>recurrence</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2021-08-05</publicationDate>
              <volume>6</volume>
              <issue>2</issue>
              <startPage>51</startPage>
              <endPage>57</endPage>
              <doi>10.26663/cts.2021.0010</doi>
              <publisherRecordId>137</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Comparing the outcomes of video-assisted thoracoscopic surgery and rethoracotomy in the management of postoperative hemorrhage</title>
                <authors>
                              <author>
                                <name>Volkan  Erdoğu</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Meral Selin Onay</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Ayşegül  Çiftçi</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Ece Yasemin Emetli</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Semih  Erduhan</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Atilla  Pekçolaklar</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Mustafa Vedat Doğru</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Yunus  Aksoy</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Ali Cevat Kutluk</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Muzaffer  Metin</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey</affiliationName><affiliationName affiliationId="2">Department of Thoracic Surgery, Bursa City Hospital, Bursa, Turkey</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background: &lt;/b&gt;Although postoperative hemorrhage after thoracic surgery is uncommon, it is the most
common indication for revision surgery after these procedures. Most postoperative hemorrhages are due
to surgical technique, although some comorbidities can predispose the patient to bleeding. We investigated
whether video-assisted thoracoscopic surgery (VATS) and re-thoracotomy had the same outcomes in the
management of postoperative hemorrhage in patients who underwent open thoracotomy or VATS.&lt;p&gt;
&lt;b&gt;Materials and Methods: &lt;/b&gt;We retrospectively analyzed patients with postoperative hemorrhage after
thoracotomy (n = 659) or VATS (n = 883) between 2018 and 2020. Revision surgery was performed
after thoracotomy in 22 patients (3.3%) and after VATS in 4 patients (0.4%). Of these, 11 patients
(42.3%) were re-operated by re-thoracotomy (Re-thoracotomy Group) and 15 patients (57.7%) by
revision VATS (VATS Group).&lt;p&gt;
&lt;b&gt;Results:&lt;/b&gt; Revision due to postoperative hemorrhage was required significantly more frequently after
thoracotomy than VATS (3.3% vs. 0.4%, p &lt; 0.001). In patients with hemorrhage after pneumonectomy
(n = 14), revision by VATS was preferred to re-thoracotomy (n = 10, 71.4% vs. n = 4, 28.6%). The
mean time to discharge after revision surgery was 5.1 ± 2.2 days (range, 2-12 days) overall and was
significantly shorter in the revision VATS Group than in the Re-thoracotomy Group (4.4 ± 1.5 days vs.
6.2 ± 2.5 days, p = 0.004).&lt;p&gt;
&lt;b&gt;Conclusions:&lt;/b&gt; VATS has similar results to re-thoracotomy and is advantageous in terms of earlier
recovery and shorter hospital stay. Therefore, VATS should be the preferred method for postoperative
hemorrhage management.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=137</fullTextUrl>
              <keywords><keyword>VATS</keyword><keyword>re-operation</keyword><keyword>thoracic surgery</keyword><keyword>thoracotomy</keyword><keyword>postoperative hemorrhage</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2021-08-05</publicationDate>
              <volume>6</volume>
              <issue>2</issue>
              <startPage>58</startPage>
              <endPage>63</endPage>
              <doi>10.26663/cts.2021.00011</doi>
              <publisherRecordId>138</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Comparison of thoracotomy and videothoracoscopy for intrathoracic bronchogenic cysts</title>
                <authors>
                              <author>
                                <name>Kenan Can Ceylan</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Hüseyin  Mestan</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Şeyda Örs Kaya</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Ali Galip Yener</name>
                                <affiliationId>2</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Dr. Suat Seren Chest Disease and Thoracic Surgery Training and Research Hospital, İzmir, Turkey</affiliationName><affiliationName affiliationId="2">Department of Pathology, Dr. Suat Seren Chest Disease and Thoracic Surgery Training and Research Hospital, İzmir, Turkey</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background:&lt;/b&gt; Bronchogenic cyst is a generally benign and rare congenital anomaly. The mediastinum and
lung parenchyma are the most common sites the cysts occur. This study aimed to compare the effectiveness
of thoracoscopy and thoracotomy for the treatment of bronchogenic cysts.&lt;p&gt;
&lt;b&gt;Materials and Methods:&lt;/b&gt; Twenty-one patients were operated on in Dr. Suat Seren Thoracic Surgery
Clinic between 2004 and 2019 with the diagnosis of bronchogenic cyst. Patients were divided into two
groups according to the surgery method as video-assisted thoracoscopic surgery (VATS) or thoracotomy.
Demographic and operative features, radiological findings, and complications were retrospectively analyzed.&lt;p&gt;
&lt;b&gt;Results: &lt;/b&gt;Patients underwent either VATS (10 patients) or thoracotomy (11 patients). Sixteen patients
underwent simple cyst excision, whereas parenchymal resection was performed for five patients. The mean
Visual Analogue Scale (VAS) value was 3.5 ± 1.1 for the VATS group and 6.5 ± 1 for the thoracotomy group.
Duration of hospital stay and chest drainage was 4.2 ± 1.7 and 3.2 ± 1.7 days, respectively, in the VATS
group, while in the thoracotomy group, it was 7.1 ± 4.5 and 6.1 ± 4.5 days. The time of hospitalization stay,
duration of chest drainage, operative time, and VAS values were found statistically significantly lower in the
VATS group.&lt;p&gt;
&lt;b&gt;Conclusions: &lt;/b&gt;Both VATS and thoracotomy are preferred surgical methods in bronchogenic cyst surgery.
VATS is superior to thoracotomy in terms of shorter hospital stay, chest drainage duration, operative time,
and lower postoperative pain level. Minimally invasive methods can be chosen safely for the treatment of
bronchogenic cyst in appropriate cases.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=138</fullTextUrl>
              <keywords><keyword>bronchogenic cyst</keyword><keyword>videothoracoscopy</keyword><keyword>thoracotomy</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2021-08-05</publicationDate>
              <volume>6</volume>
              <issue>2</issue>
              <startPage>64</startPage>
              <endPage>68</endPage>
              <doi>10.26663/cts.2021.0012</doi>
              <publisherRecordId>139</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Efficiency of vocal cord medialization for recurrent laryngeal nerve dysfunction following pulmonary resections</title>
                <authors>
                              <author>
                                <name>Melis E Demirağ</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Çağatay  Tezel</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Volkan  Baysungur</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Serdar  Evman</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>  </name>
                                <affiliationId></affiliationId>
                              </author>
                              <author>
                                <name>  </name>
                                <affiliationId></affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Otorhinolaryngology, University of Health Sciences, Kartal Dr.Lutfi Kirdar Training and Research Hospital, Istanbul, Turkey</affiliationName><affiliationName affiliationId="2">Department of Thoracic Surgery, University of Health Sciences, Sureyyapasa Training and Research Hospital, Istanbul, Turkey</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background:&lt;/b&gt; Evaluating the incidence of postoperative vocal cord dysfunction after pulmonary
resections and the impact of timing for vocal cord medialization on preventing postoperative pulmonary
complications for these patients.&lt;p&gt;
&lt;b&gt;Materials and Methods:&lt;/b&gt; Patients developing vocal cord dysfunction (VCD)/unilateral vocal cord
paralysis (UVCP) after pulmonary resection were examined retrospectively, in terms of postoperative
pulmonary complication (PPC) rates and hospital length of stay. Total of 2740 patients underwent
anatomical pulmonary resection for malignancy. Eleven patients were referred to otolaryngology team
with pre-diagnosis of VCD following the operation. UVCP diagnosis was confirmed with indirect
laryngoscopic examination.&lt;p&gt;
&lt;b&gt;Results:&lt;/b&gt; UVCP diagnosis was confirmed in 8 (0.3%) with indirect laryngoscopic examination. Performed
resections were left upper lobectomy in 3 and left pneumonectomy in 5 patients. Atelectasis necessitating
bronchoscopy and pneumonia were the PPC, seen in 3 (37.5%) patients. Calcium hydroxyapatite injection
for 6 patients and polytetrafluoroethylene graft implantation for 2 patients was performed. Mean duration
between pulmonary resection and medialization was 5.3 days in patients developing PPC and 3.6 days
in patients with no PPC (p = 0.011). All patients were discharged within an average of 8.1 (6-13) days,
uneventfully. One patient required re-injection of calcium hydroxyapatite on 5th month. Throughout a
mean follow-up duration of 14.8 months, all patients had stable vocal cord position.&lt;p&gt;
&lt;b&gt;Conclusions: &lt;/b&gt;Vocal cord medialization can be performed safely for postthoracotomy UVCP. In order to
minimize phonetic and respiratory complications, this procedure must be applied on early postoperative period.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=139</fullTextUrl>
              <keywords><keyword>acquired vocal cord palsy</keyword><keyword>complications</keyword><keyword>medialization laryngoplasty</keyword><keyword>thoracotomy</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2021-08-05</publicationDate>
              <volume>6</volume>
              <issue>2</issue>
              <startPage>69</startPage>
              <endPage>74</endPage>
              <doi>10.26663/cts.2021.0013</doi>
              <publisherRecordId>140</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Minimally invasive pectus excavatum surgery: nuss procedure</title>
                <authors>
                              <author>
                                <name>Tuba  Apaydın</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Murat  Akkuş</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Thoracic Surgery Unit, SBU Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, İstanbul, Turkey</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background:&lt;/b&gt; We reviewed pre-, intra-, and post-operative clinical data, including morbidity and mortality
rates, for patients who underwent Nuss surgery to repair pectus excavatum.&lt;p&gt;
&lt;b&gt;Materials and Methods: &lt;/b&gt;Nuss procedure was performed in 140 patients at our clinic between 2012 and
2019 (males: 108; females: 32 females; mean age: 15.7 ± 7.8 years; range: 3-40 years). The Haller index
was mild (2.5-3.2) in 72, moderate (3.2-3.5) in 40, and severe (3.6-6.0) in 28 patients.&lt;p&gt;
&lt;b&gt;Results: &lt;/b&gt;None of the patients died. Morbidity or bad blood loss was not observed. The mean duration of
surgery was 59.5 ± 21 min (range: 30-120 min). The mean duration of postoperative hospitalization was
4.6 ± 2.9 days (range: 3-19 days). The procedure was performed using one (n = 107; 76.4%), two (n = 31;
22.2%), or three (n = 2; 1.4%) bars. There were five cases of early pneumothorax, four pleural effusions,
five bar displacements, two wound infections, one hematoma, seven bar exposures due to allergies, and
three costal fractures.&lt;p&gt;
&lt;b&gt;Conclusions:&lt;/b&gt; The Nuss operation is an effective, minimally-invasive treatment for pectus excavatum. It
has the advantages of a short duration of surgery and low morbidity and mortality rates. Therefore, the
Nuss operation may be considered the treatment of choice in cases of pectus excavatum.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=140</fullTextUrl>
              <keywords><keyword>pectus excavatum</keyword><keyword>surgery</keyword><keyword>minimally invasive</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2021-08-05</publicationDate>
              <volume>6</volume>
              <issue>2</issue>
              <startPage>75</startPage>
              <endPage>77</endPage>
              <doi>10.26663/cts.2021.0014</doi>
              <publisherRecordId>141</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Late term broncho-eosophageal fistula and endoscopic treatment: a case report</title>
                <authors>
                              <author>
                                <name>Muammer Cumhur Sivrikoz</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Erhan  Durceylan</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Eskisehir Osmangazi University, School of Medicine, Eskişehir, Turkey</affiliationName></affiliationsList><abstract language="eng">Fistulas between the respiratory and digestive tract (trachea-esophageal, broncho-esophageal) can
be congenital or acquired. Acquired fistulas due to malignancy can occur by direct invasion of the
malignant tissue; or it may be a result of surgical treatment, chemotherapy or radiotherapy. Although
such fistulas occur during or shortly after treatment, it is unlikely that they will emerge long years
after treatment. We report a case of late term broncho-esophageal fistula and an endoscopic treatment
method in a patient who underwent left pneumonectomy for bronchial carcinoma. Treatment of the
patient was accomplished with bronchoscopic placement of polyglycolic acid patch with surgical tissue
glue into the fistula tract. Fistulas between trachea-bronchus and digestive tract should be kept in mind,
after surgical interventions of neighborhood structures. Bronchoscopic interventions may be a treatment
alternative in appropriate patients.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=141</fullTextUrl>
              <keywords><keyword>broncho-esophageal fistula</keyword><keyword>bronchoscopy</keyword><keyword>bronchial carcinoma</keyword><keyword>polyglycolic acid patch</keyword><keyword>surgical tissue glue</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2021-08-05</publicationDate>
              <volume>6</volume>
              <issue>2</issue>
              <startPage>78</startPage>
              <endPage>81</endPage>
              <doi>10.26663/cts.2021.0015</doi>
              <publisherRecordId>142</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Pulmonary large cell neuroendocrine carcinoma: a diagnostic challenge</title>
                <authors>
                              <author>
                                <name>Demet  Yaldız</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Mehmet Sadık Yaldız</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Ayça  Tan</name>
                                <affiliationId>2</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Manisa Celal Bayar University, Faculty of Medicine, Manisa, Turkey</affiliationName><affiliationName affiliationId="2">Department of Pathology, Manisa Celal Bayar University, Faculty of Medicine, Manisa, Turkey</affiliationName></affiliationsList><abstract language="eng">Pulmonary large cell neuroendocrine carcinoma (LCNEC) is known by its highly aggressive behaviour.
General presentation is early spread to both regional lymph nodes and distant sites. Here we present
a totally asymptomatic patient with a huge fluid-filled cystic lesion detected incidentally in a chest
radiograph.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=142</fullTextUrl>
              <keywords><keyword>large cell neuroendocrine carcinoma</keyword><keyword>pulmonary</keyword><keyword>hydatid cyst</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2021-08-05</publicationDate>
              <volume>6</volume>
              <issue>2</issue>
              <startPage>82</startPage>
              <endPage>85</endPage>
              <doi>10.26663/cts.2021.0016</doi>
              <publisherRecordId>143</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">A case of mediastinitis causing massive hemothorax</title>
                <authors>
                              <author>
                                <name>Sercan  Aydın</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Şükriye Miray Kılınçer Bozgül</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Tevfik İlker Akçam</name>
                                <affiliationId>3</affiliationId>
                              </author>
                              <author>
                                <name>Devrim  Bozkurt</name>
                                <affiliationId>2</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Kastamonu Education and Research Hospital, Kastamonu, Turkey</affiliationName><affiliationName affiliationId="2">Department of Internal Medicine, Ege University, School of Medicine, Izmir, Turkey</affiliationName><affiliationName affiliationId="3">Department of Thoracic Surgery, Ege University, School of Medicine, Izmir, Turkey</affiliationName></affiliationsList><abstract language="eng">Acute mediastinitis is an infection of the mediastinal tissue, which is a rare condition with high
mortality and morbidity usually requiring intensive care follow-up. The most common reported causes
of this condition are postoperative mediastinitis and descending necrotizing mediastinitis. The patients
of the condition usually present with nonspecific symptoms such as fever, dysphagia, and chest pain.
Laboratory findings observed are nonspecific, and also leukocytosis and high C reactive protein (CRP)
values are encountered. Heterogeneity in the mediastinal tissues, air densities in the mediastinum and
loculated fluid collections are radiologically observed. The treatment of the condition is antibiotherapy
and surgery. Hemothorax is not reported as an expected complication in the follow-up of mediastinitis.
In this case report, we present a patient with hemothorax hospitalized with the diagnosis of mediastinitis
and empyema after an extraction of a tooth.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=143</fullTextUrl>
              <keywords><keyword>abscess</keyword><keyword>empyema</keyword><keyword>hemothorax</keyword><keyword>mediastinitis</keyword>
                  </keywords>
            </record></records>